Fingerprint
Dive into the research topics of 'WITHDRAWN: Terazosin for benign prostatic hyperplasia.'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
WITHDRAWN: Terazosin for benign prostatic hyperplasia.
Timothy J. Wilt, R. William Howe, Indy Rutks, Roderick Macdonald
Research output: Contribution to journal › Review article › peer-review
10
Scopus
citations